Pulse Biosciences Completes Enrollment in AF Pivotal Study

Pulse Biosciences (PLSE) has reached its 164-evaluable-patient enrollment target for the NANOPULSE-AF IDE pivotal study of the nPulse Cardiac Catheter System. The study, conducted across 15 sites, will assess primary endpoints at six and twelve months post-ablation.